Dexcom, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Dexcom, Inc.
- Regulatory records
- 5
- Linked recall entries
- 18
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 5 FDA records to the applicant name Dexcom, Inc.. The collection includes 5 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Feb 3, 2026 to Aug 11, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QBJ appears in 2 of the 5 linked filings. The collection spans 3 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 6340 Sequence Dr., San Diego, CA, 92121, US. Recorded on K262472, decision dated Aug 11, 2026.
Device categories in this collection
Integrated Continuous Glucose Monitor For Non-Intensive Glucose Management, Over-The-Counter; Integrated Continuous Glucose Monitoring System, Factory Calibrated; Integrated Continuous Glucose Monitor For Non-Intensive Glucose Monitoring, Over-The-Counter.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Recalls linked to this firm
MedtechLedger links 18 FDA enforcement entries through the recorded recalling firm or an exact submission number published in FDA’s recall data. 10 Class I, 8 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| Dexcom, Inc. | Class II | Jul 1, 2026 | FDA | |
| Dexcom, Inc. | Class II | May 20, 2026 | FDA | |
| Dexcom, Inc. | Class II | May 20, 2026 | FDA | |
| Dexcom, Inc. | Class II | May 20, 2026 | FDA | |
| Dexcom, Inc. | Class I | Nov 5, 2025 | FDA | |
| Dexcom, Inc. | Class I | Sep 10, 2025 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Search the firm’s recall recordsSource updated Nov 11, 2026. Retrieved Nov 20, 2026.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Dexcom, Inc. | 510(k) clearance | Aug 11, 2026 | FDA | |
| Dexcom, Inc. | 510(k) clearance | Jun 12, 2026 | FDA | |
| Dexcom, Inc. | 510(k) clearance | Jun 8, 2026 | FDA | |
| Dexcom, Inc. | 510(k) clearance | May 21, 2026 | FDA | |
| Dexcom, Inc. | 510(k) clearance | Feb 3, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.





